EXECUTIVE ENGAGEMENTS
POOL
3669
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
662
Interactions with Platform & by Email
PARTICIPANTS
112
Unique # Participated
VALIDATIONS
32
Responses Validated*
COMPANIES
29
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
104
PAGES
163
EDITION
7
PRICE
USD 4950
CODE
MCP11646
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Drug Discovery Informatics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Sequencing & Target Data Analysis, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Docking segment is readjusted to a revised 8.3% CAGR for the next 7-year period.
The Drug Discovery Informatics market in the U.S. is estimated at US$591.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$657.8 Million by the year 2027 trailing a CAGR of 9.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9% and 8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8% CAGR.
In the global Molecular Modelling segment, USA, Canada, Japan, China and Europe will drive the 10.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$329.5 Million in the year 2020 will reach a projected size of US$657.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$441.1 Million by the year 2027.
SELECT PLAYERS
Certara USA, Inc.; Charles River Laboratories International, Inc.; Collaborative Drug Discovery, Inc.; Dassault Systemes; GVK Biosciences Pvt., Ltd.; IBM Corporation; Infosys Ltd.; Jubilant Life Sciences Ltd.; Novo Informatics Pvt., Ltd.; Openeye Scientific Software; PerkinElmer, Inc.; Schrodinger LLC; Selvita SA; Thermo Fisher Scientific, Inc.
SEGMENTS
» End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS), Other End-Uses) » Function (Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation, Other Functions) » Solution (Software, Services)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Dwindling Government Funding Support for Healthcare R&D, A Major Challenge for Growth in the Country |
| USA Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| USA Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| USA Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| I. METHODOLOGY |
| CANADA |
| Canada Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Drug Discovery Informatics: A Prelude |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Robust Drug Discovery Investments in Response to Growing Global Disease Burden Provides the Foundation for Growth in the Market |
| Growing Global Disease Burden Intensifies the R&D Urgency for New & Potent Drugs: Global Disease Burden (In Million DALYs (Disability-Adjusted Life Years)) for the Years 2015, 2017 & 2019 |
| Rising Drug Development Spending Acts as the Chief Catalyst for the Adoption of Drug Discovery Informatics: Global Pharmaceutical R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Migration to Data Driven Drug Development Provides the Cornerstone for Growth in the Market |
| Growing Focus on Optimizing Hit to Lead (H2L) Processes in Early Stage Drug Discovery to Benefit Growth of Drug Discovery Informatics/Chemoinformatics |
| Growing Use of In-Silico Methods in Drug Development Bodes Well for the Use of Informatics |
| The Rise of Nanoinformatics as the New Era of Research in Nanomedicine Marks the Beginning of Use of Informatics in Nanomedicine |
| Exploding Commercial Opportunity for Nanomedicine Bodes Well for the Growth of Nanoinformatics: Global Nanomedicine Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Cloud Computing Emerges to Play a Key Role in Bioinformatics |
| Cost Benefits Over In-House Informatics Helps Expand the Commercial Visibility of Outsourced Informatics |
| Continuously Evolving CRO Industry Highlights the Growing Importance & Value of Pharma R&D Outsourcing: Global Contract Research Organization (CRO) Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Robust Adoption of Bioinformatics Services Highlights the Growing Dominance of Informatics Outsourcing Over Traditional In-House Informatics: Global Bioinformatics Services Market (In US$ Billion) by Service Type for the Years 2017, 2019, 2022 and 2024 |
| Competitive Challenges Faced by the Pharma Industry & the Ensuing Need for Decision Support Tools & Collaborative Discovery Opens the Flood Gates of Opportunity for Drug Discovery Informatics |
| Rising Global Healthcare Spending Spurs Government Focus On Cost Containment Driving Pharma Companies to Cut Drug Prices by Reducing Research Costs: Global Healthcare Spending (In US$ Trillion) by Government, Private & Consumer Out-of-Pocket for the Years 2017, 2019, 2022 and 2025 |
| Productivity Gains, Acceleration of Speed & Success of Drug Discovery Research Drive Adoption of Drug Discovery Informatics |
| Move Towards Value-Based Care & the Resulting Emergence of the Era of Precision Medicine Catalyzes the Commercial Value of Drug Discovery Informatics |
| Robust Outlook for Precision Medicine Strengthens the Business Case for Drug Discovery Informatics: Global Market for Precision Medicine (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Drug Discovery Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Sequencing & Target Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Sequencing & Target Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Docking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Docking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Molecular Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Molecular Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Contract Research Organizations (CROS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Contract Research Organizations (CROS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 29 |
| CHINA |
| China Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| China Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| China Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Drug Discovery Informatics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| France Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| France Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| UK Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| UK Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com